Outcomes reported in pneumonia randomized controlled trials
A. Mathioudakis (Manchester, United Kingdom), M. Fally (Hellerup, Denmark), R. Robey (Manchester, United Kingdom), T. Willams (Manchester, United Kingdom), F. Haseeb (Manchester, United Kingdom), A. Kouta (Manchester, United Kingdom), P. Dark (Manchester, United Kingdom), A. Bentley (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), T. Felton (Manchester, United Kingdom)
Source: Virtual Congress 2021 – Pneumonia
Session: Pneumonia
Session type: E-poster
Number: 1754
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mathioudakis (Manchester, United Kingdom), M. Fally (Hellerup, Denmark), R. Robey (Manchester, United Kingdom), T. Willams (Manchester, United Kingdom), F. Haseeb (Manchester, United Kingdom), A. Kouta (Manchester, United Kingdom), P. Dark (Manchester, United Kingdom), A. Bentley (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), T. Felton (Manchester, United Kingdom). Outcomes reported in pneumonia randomized controlled trials. 1754
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019
Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD Source: International Congress 2017 – Management of COPD Year: 2017
Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial Source: Eur Respir J, 58 (4) 2002819; 10.1183/13993003.02819-2020 Year: 2021
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial) Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial Source: Eur Respir J, 59 (1) 2100752; 10.1183/13993003.00752-2021 Year: 2022
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Effectiveness of an intervention of Urban Training in patients with COPD: a randomized controlled trial Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022
Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021
Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial Source: International Congress 2019 – Airway infection in COPD Year: 2019
Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Late Breaking Abstract - CPAP treatment in the very elderly with Ostructive Sleep Apnea. Pooled results from two multicenter randomized controlled trials Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021
Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017
Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009
Efficiency of physiotherapy with Caycedian Sophrology on children with asthma: a randomized controlled trial. Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018